论文信息 - Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601 - 字舞流文

Clinical and molecular signature of survival and resistance to olaparib plus pegylated liposomal doxorubicin in platinum-resistant ovarian cancer: a stratified analysis from the phase II clinical trial ROLANDO, GEICO-1601

J. Pérez-Fidalgo | A. Oaknin | A. Redondo | A. Santaballa | E. Guerra | Y. Garcia | M. Iglesias | A. González-Martín | M. Rubio | P. Estévez-García | María Hernández-Sosa | L. Mansó Sánchez | L. M. Manso Sanchez | P. Estévez-García | L. Manso Sanchez